Small Volume Aseptic Parenteral Manufacturing
We specialize in supporting small pharma by producing small volume batches with a focus on aseptic production and providing quick turnaround for reduced lead times. Our facility is equipped with advanced technology and strict quality control measures to ensure the highest standards of safety and efficacy in aseptic filling. We offer tailored solutions, working closely with clients to accommodate their specific needs and adapt to changes in production plans. By partnering with us, small pharma companies can confidently bring their innovative products to market, relying on our commitment to excellence and our customer-centric approach to aseptic filling and production.
Equipped for Faster
Singota utilizes a Cytiva (formerly Vanrx) SA25 work-cell system consisting of automated filling, stoppering, and capping processes integrated within an isolator using VHP (Vaporized Hydrogen Peroxide) decontamination.
Our robotic aseptic filling is done in a completely gloveless environment that provides highly repeatable, precision fills for small batch manufacturing. Our System is ideally suited for the production of pre-clinical, and clinical injectable products in vial, syringe, and cartridge formats. Singota’s state-of-the-art equipment handles a wide range of small molecule, biological formulations and potent compounds.
Singota’s combination of capacity and capability is supported by deep regulatory knowledge. Clinical focus is a different sphere than commercial, and our familiarity with the regulatory process in that respect eliminates a time-consuming variable from our partnerships. We also have proven expertise in tech transfer for large-scale clinical needs and commercial manufacturing, to ensuring a smooth transition of validation of both manufacturing and analytical methods when our partners grow beyond us.
Our aseptic manufacturing process is backed by a rigorous Quality Assurance (QA) program. We prioritize quality at every step to ensure the safety, efficacy, and sterility of our products. Our state-of-the-art cleanroom facilities, environmental monitoring, and qualified personnel uphold the highest standards of cleanliness. Thorough validation and qualification processes, along with comprehensive documentation, guarantee compliance and traceability. Quality control testing, including microbial and sterility tests, ensures the integrity of our pharmaceutical products. With our robust QA process, clients can trust us to deliver precision, reliability, and compliance in their manufacturing needs.
“Operating in the drug development space – primarily for small-batch aseptic manufacturing for preclinical and clinical use — Singota is keenly aware of the project scheduling challenges faced by our clients. We have built our business with the understanding that many factors affect drug development timelines, from the intricacies of cutting-edge chemistry to the unpredictable-at-times availability of raw materials, that are often beyond our clients’ control.”
Read our article on “Scheduling Aseptic Filling for Preclinical and Clinical Batches” along with our other blogs to gain insight from our experts on this process.
The state-of-the-art aseptic filling technology offers:
Fast turnaround and shortened lead-times
Standard container formats – nested, pre-sterilized configurations
Vial, syringe, and cartridge filling
Single use, disposable components for product contact pathway
Gloveless, robotic technology providing robust contamination controls
Automated check weight capability and pump setting adjustments
Minimized line losses, preserving scarce and expensive drug products
Singota focuses on small batch aseptic filling runs for: